Unternehmensübersicht
Phaos Technology Holdings (Cayman) Limited operates within the healthcare sector, specifically focusing on the medical devices industry, where it develops and commercializes advanced microscopy-related solutions, technologies, and products. The company executes its manufacturing and commercialization activities through its subsidiary, Phaos Technology Pte. Ltd., which is headquartered in Singapore. Phaos Technology Holdings (Cayman) Limited currently maintains a market capitalization of $21.93M and employs a workforce of 25 individuals. With a trailing twelve-month revenue of $167,707, the company operates on a micro-cap scale, indicating a small market presence relative to larger established medical device manufacturers. The combination of a $21.93M market cap and revenue figures under $200,000 suggests that the company is in an early-stage development phase or is facing significant headwinds in its commercialization efforts. This limited scale implies that the firm is likely prioritizing product iteration and market entry over profitability or broad market dominance at this specific moment in its lifecycle.
Finanzielle Gesundheit
The company reported a revenue of $167,707 over the trailing twelve-month period, yet this generated a net income of $-5,137,064, revealing a profound structural disconnect between top-line sales and bottom-line profitability. This massive gap between the modest revenue and the substantial net loss highlights an extremely aggressive burn rate or significant one-time expenses that are not proportionate to current sales volumes. The EBITDA for the period stood at $-3,869,313, further emphasizing that the core operational cash generation is insufficient to cover existing costs and capital expenditures. Free cash flow amounted to $-1,657,362, indicating that the company is consuming cash reserves rather than generating liquidity from its primary business operations. Profitability is severely compromised across all metrics, with a gross margin of 22.1%, an operating margin of -1897.8%, and a profit margin of 0.0%, which collectively signal that the company is currently unable to convert its sales into sustainable earnings. On the balance sheet side, the company holds $177,660 in cash against $3.26M in debt, creating a situation where liabilities significantly exceed liquid assets. The debt-to-equity ratio is listed as N/A due to the specific financial structure or lack of equity in the denominator, while the current ratio of 0.40 indicates that current liabilities exceed current assets by more than double. This liquidity position suggests a high risk of short-term solvency challenges unless external financing is secured or operational efficiency improves dramatically. Furthermore, the return on equity stands at -1073.1% and the return on assets at -71.2%, metrics that demonstrate how capital deployed by shareholders and creditors is currently generating substantial negative returns rather than value accretion.
Bewertungsanalyse
Valuation multiples for Phaos Technology Holdings are unavailable in traditional terms, as the P/E ratio (TTM) and forward P/E are both N/A due to the company's lack of net income. The price-to-book ratio is reported at -27.23, a negative figure that typically indicates an accounting anomaly, a distressed state, or a situation where book value is negative, rather than a standard market premium over tangible assets. Instead of earnings-based metrics, investors often look to alternative valuation indicators such as the price-to-sales ratio of 130.77 and an EV/EBITDA of -11.44, both of which suggest the market is pricing the stock based on speculative growth potential rather than current financial performance. The stock price has exhibited significant volatility, with a 52-week high of $7.39 and a 52-week low of $0.53, representing a trading range of over 13-fold. Without a specific current price to calculate the exact percentage distance from these bounds, the asset is understood to trade within this wide band, reflecting high uncertainty regarding its fair value. The beta is listed as N/A, which implies that the stock's price volatility relative to the broader market index cannot be statistically determined due to insufficient trading volume or price data history. These valuation characteristics combined with negative financial multiples underscore the speculative nature of the investment and the absence of traditional valuation anchors.
Growth & Income
The company's revenue growth year-over-year is listed as -93.1%, indicating a severe contraction in sales, while earnings growth is N/A because the company has not posted positive earnings in recent periods. The fact that earnings are not growing faster than revenue is moot given that both metrics are heavily distorted by the loss-making status and the drastic decline in revenue. As a non-dividend payer, Phaos Technology Holdings does not distribute a dividend yield or pays out a payout ratio of 0.0%, meaning all retained earnings are theoretically available for reinvestment, though the company is currently burning cash instead. The overall growth and income profile is characterized by a deep contraction in revenue, a complete absence of profit generation, and a lack of shareholder returns through dividends. This profile suggests a company that is struggling to stabilize its revenue streams and has not yet reached a stage where it can sustainably fund growth or return capital to shareholders.